首页> 美国卫生研究院文献>ASN NEURO >Pre- and Posttreatment With Edaravone Protects CA1 Hippocampus and Enhances Neurogenesis in the Subgranular Zone of Dentate Gyrus After Transient Global Cerebral Ischemia in Rats
【2h】

Pre- and Posttreatment With Edaravone Protects CA1 Hippocampus and Enhances Neurogenesis in the Subgranular Zone of Dentate Gyrus After Transient Global Cerebral Ischemia in Rats

机译:依达拉奉的预处理和后处理可保护大鼠短暂性全脑缺血后海马CA1海马并增强齿状回亚颗粒区的神经发生。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Edaravone is clinically used for treatment of patients with acute cerebral infarction. However, the effect of double application of edaravone on neurogenesis in the hippocampus following ischemia remains unknown. In the present study, we explored whether pre- and posttreatment of edaravone had any effect on neural stem/progenitor cells (NSPCs) in the subgranular zone of hippocampus in a rat model of transient global cerebral ischemia and elucidated the potential mechanism of its effects. Male Sprague-Dawley rats were divided into three groups: sham-operated (n = 15), control (n = 15), and edaravone-treated (n = 15) groups. Newly generated cells were labeled by 5-bromo-2-deoxyuridine. Immunohistochemistry was used to detect neurogenesis. Terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick-end labeling was used to detect cell apoptosis. Reactive oxygen species (ROS) were detected by 2,7-dichlorofluorescien diacetate assay in NSPCs in vitro. Hypoxia-inducible factor-1α (HIF-1α) and cleaved caspase-3 proteins were quantified by western blot analysis. Treatment with edaravone significantly increased the number of NSPCs and newly generated neurons in the subgranular zone (p < .05). Treatment with edaravone also decreased apoptosis of NSPCs (p < .01). Furthermore, treatment with edaravone significantly decreased ROS generation and inhibited HIF-1α and cleaved caspase-3 protein expressions. These findings indicate that pre- and posttreatment with edaravone enhances neurogenesis by protecting NSPCs from apoptosis in the hippocampus, which is probably mediated by decreasing ROS generation and inhibiting protein expressions of HIF-1α and cleaved caspase-3 after cerebral ischemia.
机译:依达拉奉在临床上用于治疗急性脑梗死患者。然而,依达拉奉两次应用对缺血后海马神经发生的影响尚不清楚。在本研究中,我们探讨了依达拉奉的预处理和后处理是否对短暂性全脑缺血模型的海马亚颗粒区的神经干/祖细胞(NSPC)有任何影响,并阐明了其作用的潜在机制。将雄性Sprague-Dawley大鼠分为三组:假手术组(n = 15),对照组(n = 15)和依达拉奉治疗的组(n = 15)。用5-溴-2-脱氧尿苷标记新产生的细胞。免疫组织化学用于检测神经发生。末端脱氧核苷酸转移酶介导的dUTP-生物素缺口末端标记用于检测细胞凋亡。在体外NSPCs中通过2,7-二氯二氟乙烷双乙酸盐测定法检测了活性氧(ROS)。通过蛋白质印迹分析定量低氧诱导因子-1α(HIF-1α)和裂解的caspase-3蛋白。依达拉奉治疗显着增加了颗粒下区域NSPCs和新产生的神经元的数量(p <0.05)。依达拉奉治疗还减少了NSPCs的凋亡(p <.01)。此外,用依达拉奉治疗可显着降低ROS的产生,并抑制HIF-1α和裂解的caspase-3蛋白表达。这些发现表明,依达拉奉的预处理和后处理可通过保护NSPC免受海马细胞凋亡来增强神经发生,这可能是通过减少ROS生成并抑制脑缺血后HIF-1α和Caspase-3的蛋白表达来介导的。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号